• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • Spanish
  • English

HERA signs Joint Procurement contract for Pandemic Influenza Vaccine

Inicio » EU News » Health » Diseases » HERA signs Joint Procurement contract for Pandemic Influenza Vaccine

28 de July de 2022

Today, the European Commission, via its Health Emergency Preparedness and Response Authority, signed a framework contract for the joint procurement of Adjupanrix, a pandemic influenza vaccine, with the pharmaceutical company GSK.

manos sosteniendo una jeringuilla y una vacuna

12 Member States and other joint procurement countries are participating in the agreement, under which they can purchase up to 85,000,000 vaccine doses if necessary, in the event of an influenza pandemic.

Stella Kyriakides, European Commissioner for Health and Food Safety, said:

“Preparedness is key in a health emergency. COVID-19 has shown this beyond any doubt. Today we secure up to 85 million influenza pandemic vaccine doses through our Health Emergency and Preparedness Response Authority, to protect our citizens should such an emergency arise in the future. This is a true European Health Union in action.” 

An influenza pandemic would be a global epidemic caused by a new influenza strain to which there is little to no pre-existing immunity in the human population. While it is difficult to predict an influenza pandemic, it is important to be prepared.

List of top-3 health threats to prepare against

Background

The Commission is committed to build a stronger and active European Health Union that is prepared and able to respond to emerging health threats. The COVID-19 pandemic showed the importance of coordination among European countries and the added-value of a common response in face of cross-border health threats.

The EU’s Joint Procurement Agreement offers the 36 participating countries to jointly procure medical counter-measures as an alternative or complement to procurement at national level.

The aim of the joint procurement mechanism is to secure a more equitable access to specific medical countermeasures and to improve the security of supply, together with more balanced prices for the participating EU countries.

Start of delivery of vaccines in response to the monkeypox outbreak

 

In order to be adequately prepared for an outbreak of a serious cross-border threat to health, the institutions of the EU, together with countries that have joined the JPA, may engage in a joint procurement procedure with a view to purchase vaccines, antivirals, and medical countermeasures for serious cross-border threats to health. HERA continues to work closely with the participating countries to identify and implement priorities, such as vaccines or therapeutics, for joint procurement.

More information: European Commission – Press release

Publicaciones relacionadas:

European Commission unveils EU vaccines strategy European Commission authorises second safe and effective vaccine against COVID-19 EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca EU urges AstraZeneca to explain vaccine delivery delays EMA clears Pfizer’s third dose for the general adult population

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

European Commission unveils EU vaccines strategy European Commission authorises second safe and effective vaccine against COVID-19 EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca EU urges AstraZeneca to explain vaccine delivery delays EMA clears Pfizer’s third dose for the general adult population

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información